Citadel Advisors’s Bioceres Crop Solutions BIOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,300
Closed -$77.3K 12779
2025
Q2
$77.3K Sell
17,300
-6,100
-26% -$27.5K ﹤0.01% 11518
2025
Q1
$107K Buy
23,400
+16,800
+255% +$92.5K ﹤0.01% 11363
2024
Q4
$40.1K Sell
6,600
-3,000
-31% -$20.5K ﹤0.01% 12609
2024
Q3
$75.6K Buy
9,600
+1,400
+17% +$14.1K ﹤0.01% 11473
2024
Q2
$91.9K Buy
8,200
+1,800
+28% +$21K ﹤0.01% 11037
2024
Q1
$81K Buy
6,400
+2,300
+56% +$30.3K ﹤0.01% 11636
2023
Q4
$56.3K Sell
4,100
-28,200
-87% -$330K ﹤0.01% 11656
2023
Q3
$365K Buy
32,300
+28,300
+708% +$339K ﹤0.01% 8748
2023
Q2
$53.4K Sell
4,000
-3,000
-43% -$35.2K ﹤0.01% 11722
2023
Q1
$81.3K Sell
7,000
-10,800
-61% -$127K ﹤0.01% 11533
2022
Q4
$214K Sell
17,800
-2,500
-12% -$32.5K ﹤0.01% 9997
2022
Q3
$264K Buy
+20,300
New +$249K ﹤0.01% 9841
2022
Q2
Sell
-14,900
Closed -$203K 12890
2022
Q1
$203K Buy
+14,900
New +$197K ﹤0.01% 11501

Other funds holding BIOX

Citadel Advisors's BIOX Position: Q4 2025 in Review

Citadel Advisors sold out of Bioceres Crop Solutions (BIOX) in Q4 2025, closing a stake of 143,748 shares — an estimated $230K sold.

Citadel Advisors first reported a position in BIOX in Q1 2021 and held it in 11 quarters. The position peaked at $974K in Q4 2022. 37 funds tracked by Wall St. Rank hold BIOX as of Q4 2025.

  • Citadel Advisors reported no remaining Bioceres Crop Solutions position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 143,748 Bioceres Crop Solutions shares in Q4 2025, an estimated $230K.
  • Citadel Advisors first reported a position in Bioceres Crop Solutions in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Bioceres Crop Solutions position peaked at $974K in Q4 2022.
  • 37 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.